AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21279478 — intervention group
Group type: COMPARATOR
Intervention: No 5-ASA medications
Number of subjects: 149
Study 20709109 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyethyl cellulose (HEC) gel
Number of subjects: 0
Study 20709109 — intervention group
Group type: COMPARATOR
Intervention: Methylcellulose (MC) gel
Number of subjects: 0
Study 20709109 — intervention group
Group type: COMPARATOR
Intervention: Thin gel layers in Transwell system
Number of subjects: 0
Study 18004139 — intervention group
Group type: EXPERIMENTAL
Intervention: levodopa (100 mg)
Number of subjects: 13
Study 18004139 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 13
Study 15882720 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen injection
Number of subjects: 133
Study 15882720 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 133
Study 12640085 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with trigeminal neuralgia, right carotid artery AIx
Number of subjects: 32
Study 12640085 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with trigeminal neuralgia, left carotid artery AIx
Number of subjects: 32
Study 12640085 — intervention group
Group type: COMPARATOR
Intervention: Control group, right carotid artery AIx
Number of subjects: 32
Study 12640085 — intervention group
Group type: COMPARATOR
Intervention: Control group, left carotid artery AIx
Number of subjects: 32
Study 12640085 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with trigeminal neuralgia, ascending aorta AIx
Number of subjects: 32
Study 12640085 — intervention group
Group type: COMPARATOR
Intervention: Control group, ascending aorta AIx
Number of subjects: 32
Study 12640085 — intervention group
Group type: COMPARATOR
Intervention: Comparison of right carotid artery AIx
Number of subjects: 32
Study 12640085 — intervention group
Group type: COMPARATOR
Intervention: Comparison of left carotid artery AIx
Number of subjects: 32
Study 12640085 — intervention group
Group type: COMPARATOR
Intervention: Comparison of ascending aorta AIx
Number of subjects: 32
Study 11203756 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin injection after tooth grinding (exercise session)
Number of subjects: 10
Study 11203756 — intervention group
Group type: COMPARATOR
Intervention: Capsaicin injection without tooth grinding (non-exercise session)
Number of subjects: 10
Study 8866629 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg) administered in the morning
Number of subjects: 11
Study 8866629 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg) administered in the evening
Number of subjects: 11
Study 8866629 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg) administered in the morning or evening
Number of subjects: 11
Study 1506394 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroprusside infusion
Number of subjects: 9
Study 1506394 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion
Number of subjects: 9
Study 6143185 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem plus cilastatin (I/C group)
Number of subjects: 163
Study 6143185 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin and clindamycin (G/C group)
Number of subjects: 163
Study 31924355 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic sleeve lobectomy
Number of subjects: 188
Study 31924355 — intervention group
Group type: COMPARATOR
Intervention: Video-assisted thoracoscopic surgery (VATS)
Number of subjects: 188
Study 31924355 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 188
Study 29866601 — intervention group
Group type: EXPERIMENTAL
Intervention: ICT/CCRT
Number of subjects: 151
Study 29866601 — intervention group
Group type: COMPARATOR
Intervention: CCRT
Number of subjects: 151
Study 28169885 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated sleep restriction (4 h of sleep/night from 0300 to 0700 h for three nights followed by recovery sleep of 8 h, repeated four times in succession)
Number of subjects: 45
Study 28169885 — intervention group
Group type: COMPARATOR
Intervention: Sleep control group (8 h/night from 2300 to 0700 h)
Number of subjects: 45
Study 26666457 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorimotor training (SMT) with 15 minutes added to standard physiotherapy (PT) treatment
Number of subjects: 20
Study 26666457 — intervention group
Group type: COMPARATOR
Intervention: Standard physiotherapy (PT) treatment with 15 minutes of sub-effective low-intensity endurance training
Number of subjects: 20
Study 26666457 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group (n=20) for cross-sectional comparison
Number of subjects: 20
Study 23544761 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherent lifestyle participants
Number of subjects: 0
Study 23544761 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherent metformin participants
Number of subjects: 0
Study 23544761 — intervention group
Group type: COMPARATOR
Intervention: Placebo participants
Number of subjects: 0
Study 21140360 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutureless StatLock attachment device
Number of subjects: 72
Study 21140360 — intervention group
Group type: COMPARATOR
Intervention: Traditional suture fixation
Number of subjects: 72
Study 17578859 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D levels measured every 3 months and at relapse
Number of subjects: 23
Study 17578859 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact parathyroid hormone (iPTH) levels measured every 3 months and at relapse
Number of subjects: 23
Study 17578859 — intervention group
Group type: COMPARATOR
Intervention: MRI burden of disease and T2 activity assessed every 6 months
Number of subjects: 23
Study 17578859 — intervention group
Group type: COMPARATOR
Intervention: Seasonal variation of 25(OH)D
Number of subjects: 23
Study 17578859 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D deficiency defined as S-25(OH)D < or = 37 nmol/l
Number of subjects: 23
Study 17578859 — intervention group
Group type: COMPARATOR
Intervention: Calcium, phosphate, magnesium, chloride, alkaline phosphatase, albumin, and thyroid stimulating hormone levels measured
Number of subjects: 23
Study 16413145 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple-based interventions to facilitate risk communication and promote condom use among male IDUs
Number of subjects: 22
Study 12734710 — intervention group
Group type: EXPERIMENTAL
Intervention: Kennedy ligament augmentation device (LAD)
Number of subjects: 40
Study 12734710 — intervention group
Group type: COMPARATOR
Intervention: Conventional medial patellar tendon strip procedure
Number of subjects: 40
Study 10706012 — intervention group
Group type: EXPERIMENTAL
Intervention: Turkish patients (Tr-Pat)
Number of subjects: 150
Study 10706012 — intervention group
Group type: COMPARATOR
Intervention: German patients (G-Pat)
Number of subjects: 150
Study 10706012 — intervention group
Group type: EXPERIMENTAL
Intervention: Turkish patients (Tr-Pat) with 'bad' German knowledge
Number of subjects: 150
Study 10706012 — intervention group
Group type: EXPERIMENTAL
Intervention: Turkish patients (Tr-Pat) with 'good' German knowledge
Number of subjects: 150
Study 9366820 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral terbinafine 250 mg/day for 12 or 24 weeks
Number of subjects: 358
Study 1383825 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (8 mg SL daily)
Number of subjects: 0
Study 1383825 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (8 mg SL every other day)
Number of subjects: 0
Study 1383825 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine
Number of subjects: 0
Study 6427848 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithicarb (standard lithium carbonate preparation)
Number of subjects: 14
Study 6427848 — intervention group
Group type: EXPERIMENTAL
Intervention: Priadel (sustained-release lithium carbonate preparation)
Number of subjects: 14
Study 30875527 — intervention group
Group type: EXPERIMENTAL
Intervention: ADSTEP (Assistive Device Selection, Training and Education Program) - a multicomponent program of walking aid selection, fitting and six weekly progressive task‐oriented walking aid training sessions
Number of subjects: 14
Study 30312957 — intervention group
Group type: EXPERIMENTAL
Intervention: Zero-time exercise (ZTEx)
Number of subjects: 37
Study 30312957 — intervention group
Group type: COMPARATOR
Intervention: Sleep hygiene education (SHE)
Number of subjects: 37
Study 27146373 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily training for 12 weeks in phoneme/grapheme mapping, reading comprehension, and reading speed (Intervention group, n=47)
Number of subjects: 57
Study 27146373 — intervention group
Group type: COMPARATOR
Intervention: Ordinary classroom activities (Control group, n=37)
Number of subjects: 57
Study 27146373 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=47)
Number of subjects: 57
Study 27146373 — intervention group
Group type: COMPARATOR
Intervention: Typically developing students (n=66)
Number of subjects: 57
Study 27146373 — intervention group
Group type: COMPARATOR
Intervention: Poor readers identified in grade 2 (n=2212)
Number of subjects: 57
Study 24498399 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWF-5A (4 mL or 10 mL)
Number of subjects: 329
Study 24498399 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control (saline)
Number of subjects: 329
Study 23300745 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine 37.5 mg/sqm
Number of subjects: 12
Study 23300745 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine 75 mg/sqm
Number of subjects: 12
Study 23300745 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy (7+3 cytarabine plus daunorubicin and intermediate-dose cytarabine)
Number of subjects: 12
Study 20591173 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ibuprofen 100 mg
Number of subjects: 120
Study 20591173 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ibuprofen 200 mg
Number of subjects: 120
Study 20591173 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ibuprofen 400 mg
Number of subjects: 120
Study 20591173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 18219959 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 110
Study 18219959 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 110
Study 15802911 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation (verum group)
Number of subjects: 62
Study 15802911 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 62
Study 11940545 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker nebivolol 5 mg daily
Number of subjects: 3741
Study 9588378 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 48
Study 9588378 — intervention group
Group type: COMPARATOR
Intervention: Low dose haloperidol
Number of subjects: 48
Study 8746104 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefatrizine at a dose of 1 g/day for 10 days
Number of subjects: 250
Study 8746104 — intervention group
Group type: COMPARATOR
Intervention: Cefpodoxime proxetil at a dose of 400 mg/day for 10 days
Number of subjects: 250
Study 8746104 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefatrizine
Number of subjects: 250
Study 8746104 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefatrizine and Cefpodoxime proxetil
Number of subjects: 250
Study 2693918 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (50 mg i.m. every 3 or 4 weeks)
Number of subjects: 22
Study 2693918 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate withdrawal
Number of subjects: 22
Study 2693918 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate therapy
Number of subjects: 22
Study 322696 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous BCG treatment
Number of subjects: 81
Study 322696 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy only (DNR/ARAC)
Number of subjects: 81
Study 322696 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG treated group
Number of subjects: 81
Study 31299343 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated Growth Factor (CGF)
Number of subjects: 60
Study 31299343 — intervention group
Group type: COMPARATOR
Intervention: Control (non-CGF)
Number of subjects: 60
Study 30802689 — intervention group
Group type: EXPERIMENTAL
Intervention: AL 441 mg
Number of subjects: 0
Study 30802689 — intervention group
Group type: EXPERIMENTAL
Intervention: AL 882 mg
Number of subjects: 0
Study 30802689 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28799128 — intervention group
Group type: COMPARATOR
Intervention: Epidural catheter (group C)
Number of subjects: 154
Study 28799128 — intervention group
Group type: EXPERIMENTAL
Intervention: No epidural catheter (group N)
Number of subjects: 154
Study 26012779 — intervention group
Group type: EXPERIMENTAL
Intervention: AFXL-assisted PDT with 90 min incubation time
Number of subjects: 46
Study 26012779 — intervention group
Group type: COMPARATOR
Intervention: Conventional PDT with 180 min incubation time
Number of subjects: 46
Study 25627186 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT)
Number of subjects: 40
Study 25627186 — intervention group
Group type: COMPARATOR
Intervention: Anterior stromal puncture (ASP)
Number of subjects: 40
Study 22111821 — intervention group
Group type: EXPERIMENTAL
Intervention: Postdilutional online hemodiafiltration (oHDF)
Number of subjects: 54
Study 22111821 — intervention group
Group type: COMPARATOR
Intervention: High-flux hemodialysis (HD)
Number of subjects: 54
Study 19732311 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil 10 mg or 20 mg
Number of subjects: 52
Study 19732311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 17713974 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg (oral administration)
Number of subjects: 32
Study 17713974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 15921803 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (non-selective beta-blocker)
Number of subjects: 22
Study 15921803 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol (selective beta-blocker)
Number of subjects: 22
Study 11825813 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta irradiation (750 cGy)
Number of subjects: 61
Study 11825813 — intervention group
Group type: COMPARATOR
Intervention: Control (inactive applicator)
Number of subjects: 61
Study 10489259 — intervention group
Group type: EXPERIMENTAL
Intervention: Categorization task with familiar stimuli
Number of subjects: 0
Study 10489259 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition task with familiar stimuli
Number of subjects: 0
Study 8599282 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 300 mg administered in a 120 min iv infusion
Number of subjects: 25
Study 8599282 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identically looking to PTX)
Number of subjects: 25
Study 2698515 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg Cinoxacin b.i.d. for 5 days
Number of subjects: 37
Study 2698515 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 37
Study 1095116 — intervention group
Group type: EXPERIMENTAL
Intervention: Biochemical profile
Number of subjects: 2816
Study 30967597 — intervention group
Group type: EXPERIMENTAL
Intervention: UGT2B17*2
Number of subjects: 125
Study 30967597 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP19A1 rs10046 AA vs. AG/GG genotypes
Number of subjects: 125
Study 30967597 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP19A1 low estrogen alleles rs10046 G and rs4646 A
Number of subjects: 125
Study 30611694 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 suture technique
Number of subjects: 37
Study 30611694 — intervention group
Group type: COMPARATOR
Intervention: sutureless technique
Number of subjects: 37
Study 28697504 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling vest during physical training program
Number of subjects: 18
Study 28697504 — intervention group
Group type: COMPARATOR
Intervention: Cotton T-shirt during physical training program
Number of subjects: 18
Study 26531075 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect pulp treatment (IPT)
Number of subjects: 96
Study 26531075 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal caries removal with both resin‐modified glass ionomer base material and luting cement (MCRB/L)
Number of subjects: 96
Study 26531075 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal caries removal with only resin‐modified glass ionomer luting cement (MCRL)
Number of subjects: 96
Study 23627832 — intervention group
Group type: EXPERIMENTAL
Intervention: DBX (thermogenic dietary supplement containing 340 mg of total caffeine plus green tea extract, yerba mate extract, carnitine tartrate)
Number of subjects: 12
Study 23627832 — intervention group
Group type: EXPERIMENTAL
Intervention: DBX
Number of subjects: 12
Study 21628014 — intervention group
Group type: COMPARATOR
Intervention: PillCam SB2
Number of subjects: 73
Study 21628014 — intervention group
Group type: EXPERIMENTAL
Intervention: MiroCam capsule
Number of subjects: 73
Study 21628014 — intervention group
Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 73
Study 19702600 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RF-ablation) for AVNRT and WPW syndrome
Number of subjects: 176
Study 19702600 — intervention group
Group type: EXPERIMENTAL
Intervention: AVNRT
Number of subjects: 176
Study 19702600 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodes of tachycardia more than once a month
Number of subjects: 176
Study 19702600 — intervention group
Group type: EXPERIMENTAL
Intervention: Arrhythmia duration longer than one hour
Number of subjects: 176
Study 19702600 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms during activity and at rest
Number of subjects: 176
Study 16923310 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine
Number of subjects: 1200
Study 16923310 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant therapy
Number of subjects: 1200
Study 16923310 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine and antioxidant therapy
Number of subjects: 1200
Study 16923310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study 16923310 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 1200
Study 15273211 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% of MVIC
Number of subjects: 72
Study 15273211 — intervention group
Group type: EXPERIMENTAL
Intervention: 60% of MVIC
Number of subjects: 72
Study 15273211 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% MVIC
Number of subjects: 72
Study 15273211 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stretching)
Number of subjects: 72
Study 12505808 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% testosterone gel, 10 g/day
Number of subjects: 23
Study 12505808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 9856366 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril at 50 mg twice a day
Number of subjects: 18
Study 9856366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 8587096 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatology case report forms
Number of subjects: 30
Study 8587096 — intervention group
Group type: COMPARATOR
Intervention: Structured instruments from other disciplines
Number of subjects: 30
Study 1694945 — intervention group
Group type: EXPERIMENTAL
Intervention: Xamoterol 200 mg twice daily for 13 weeks
Number of subjects: 516
Study 1694945 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily for 13 weeks
Number of subjects: 516
Study 1694945 — intervention group
Group type: EXPERIMENTAL
Intervention: Xamoterol 200 mg
Number of subjects: 516
Study 1694945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 516
Study 41475 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg i.v. dose of labetalol
Number of subjects: 18
Study 41475 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg/kg i.v. dose of labetalol
Number of subjects: 18
Study 27997257 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate bar
Number of subjects: 12
Study 27997257 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate gel
Number of subjects: 12
Study 27997257 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate drink
Number of subjects: 12
Study 27997257 — intervention group
Group type: COMPARATOR
Intervention: Mixed carbohydrate formats
Number of subjects: 12
Study 25427033 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Hz rTMS
Number of subjects: 10
Study 25427033 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 10
Study 25427033 — intervention group
Group type: COMPARATOR
Intervention: 5-Hz rTMS and Anodal tDCS
Number of subjects: 10
Study 23870127 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynein targeting to the cell cortex via Gαi/LGN/NuMA-dependent pathway and 4.1G/R and NuMA-dependent pathway
Number of subjects: 0
Study 23870127 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymmetric plasma membrane elongation in response to spindle mispositioning
Number of subjects: 0
Study 23870127 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynein-dependent spindle anchoring at the stationary cell cortex
Number of subjects: 0
Study 22462237 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency electric sparkle and point-injection therapy (HESPT)
Number of subjects: 205
Study 22462237 — intervention group
Group type: COMPARATOR
Intervention: Warming needle moxibustion
Number of subjects: 205
Study 22462237 — intervention group
Group type: COMPARATOR
Intervention: Point-injection therapy
Number of subjects: 205
Study 19699853 — intervention group
Group type: EXPERIMENTAL
Intervention: SCH 530348 in addition to standard of care
Number of subjects: 10000
Study 19699853 — intervention group
Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 10000
Study 17116522 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/AIDS educational intervention
Number of subjects: 200
Study 15146228 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic touch (TT) plus dialogue nursing intervention
Number of subjects: 18
Study 15146228 — intervention group
Group type: COMPARATOR
Intervention: Quiet time plus dialogue nursing intervention
Number of subjects: 18